FDA clears Novavax COVID-19 vaccine for emergency use in US


Americans will likely have another COVID-19 vaccine to choose from after the Food and Drug Administration issued an emergency use authorization for Novavax’s COVID-19 vaccine on Wednesday.

It has been cleared for use in persons 18 years of age and older.

Novavax is the fourth COVID-19 vaccine to receive emergency use authorization in the United States from the FDA.

This is a developing story. Check back for updates.

ABC News

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button